Science
Drug Reports
Read full drug reports from Thomson Reuters. Over 40,000 are available in Thomson Reuters Cortellis for Competitive Intelligence. Find out more about Thomson Reuters Cortellis for Competitive Intelligence and take a free two week trial to see what Thomson Reuters Cortellis for Competitive Intelligence can do for you.
- Adalimumab (trade name Humira)
- Bevacizumab (trade name Avastin)
- Celecoxib (trade name Celecox and Celebrex)
- Cetuximab (trade name Erbitux)
- Duloxetine (trade name Symbalta, Cymbalta, Xeristar, Yentreve, Ariclaim and Duloxetine Boehringer Ingelheim)
- Erlotinib (trade name Tarceva)
- Etanercept (trade name Enbrel and Enbrel SureClick)
- Imatinib (trade name Gleevec and Glivec)
- Infliximab (trade name Avakine and Remicade)
- Pregabalin (trade name Lyrica)
Feedback